Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2013

View Archived Issues

Jazz Pharmaceuticals presents company outlook

Discovery of novel dual NK1 receptor antagonist/SERT inhibitor for the treatment of depression

International Stem Cell tests its hpSC-derived hepatocytes in vivo

Bosutinib receives positive CHMP opinion for conditional marketing authorization

CHMP recommends approval of Jetrea in Europe for vitreomacular traction

Novel antibacterials created by Kyorin and Merck & Co.

YH-GKA identified as a novel glucokinase activator for treating diabetes

New HDAC6 inhibitors designed at U.S. institutes

Researchers design a gene knockout mouse using TALEN-mediated mutagenesis in zygotes

State University of New Jersey patents novel RNA polymerase bipartite inhibitors

Research at Myrexis yields new NAmPRTase inhibitors

Research at Roche and Genentech disclose novel PC9-binding peptides

University of Pittsburgh designs novel H1N1 influenza vaccines

Serina Therapeutics partners with AstraZeneca

Cancer Research UK and AstraZeneca begin clinical development of AZD-0424

Hexal presents new prodrugs of cilazapril

FDA approves Botox for overactive bladder

EMA confirms recommendation to suspend nicotinic acid/laropiprant

Roche presents new HCV therapeutics

Recordati completes acquisition of certain Lundbeck products

Phase II trial of ponatinib in squamous cell lung cancer begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...